Efficacy and safety of new oral anticoagulants combined with antiplatelet drugs in the treatment of coronary heart disease: Systematic evaluation and meta‐analysis

OBJECTIVE: To analyze the efficacy and safety of antiplatelet drugs combined with new oral anticoagulants (noac) in the treatment of coronary atherosclerotic heart disease (CAD). METHODS: The randomized controlled trials of noac combined with antiplatelet therapy in Cochrane, CNKI, PubMed, EMBASE, W...

Descripción completa

Detalles Bibliográficos
Autores principales: Saiyitijiang, Alimila, Aizezi, Mayila, Zhao, Ying, Gao, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484016/
https://www.ncbi.nlm.nih.gov/pubmed/35715952
http://dx.doi.org/10.1111/anec.12977

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9484016/
https://www.ncbi.nlm.nih.gov/pubmed/35715952
http://dx.doi.org/10.1111/anec.12977

Ejemplares similares